申请人:Cheng Hengmiao
公开号:US20070027118A1
公开(公告)日:2007-02-01
The present invention relates to compounds with formula (I) or a pharmaceutically acceptable salt thereof:
wherein;
T is a (4 to 10)-membered heterocyclyl and wherein R
1
, R
2
and R
3
are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of the 11-β-hsd-1 enzyme.
本发明涉及具有公式(I)或其药学上可接受的盐的化合物:其中;T是(4至10)成员的杂环基,其中R1,R2和R3如规范中所定义。本发明还涉及包含公式(I)化合物的药物组合物以及治疗通过调节11-β-hsd-1酶介导的疾病的方法。